Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.
The peptide therapeutics market is forecasted to grow by USD 17.85 billion during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period.
This report provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.
The market is driven by increasing prevalence of infectious diseases, availability of favorable reimbursement policies, and drugs with extended half-life.
This study identifies the collaborations for R&D as one of the prime reasons driving the peptide therapeutics market growth during the next few years. Also, strong pipeline of peptide therapeutics and advent of novel technologies will lead to sizable demand in the market.
The peptide therapeutics market is segmented as below:
- By Route of Administration
- Parenteral
- Oral
- Others
- By Geography
- North America
- Europe
- Asia
- Rest of World (RoW)
A robust vendor analysis was designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading peptide therapeutics market vendors.
Also, the peptide therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
A selection of companies mentioned in this report includes, but is not limited to:
- Almac Group Ltd.
- AmbioPharm Inc.
- Amgen Inc.
- AstraZeneca PLC
- Bachem AG
- Bristol Myers Squibb Co.
- Corden Pharma International GmbH
- Eli Lilly and Co.
- Ever Pharma
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline PLC
- Ipsen Pharma
- Lonza Group Ltd.
- Novartis AG
- Novo Nordisk AS
- PeptiDream Inc.
- Pfizer Inc.
- PolyPeptide Group
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Worg pharma
For more information about this report visit https://www.researchandmarkets.com/r/rnyimm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
